We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Vaidya Sane Ayurved Laboratories Ltd., operating commercially as Madhavbaug, is an Indian specialist healthcare provider focused on the non-invasive treatment and management of lifestyle-related chronic diseases, primarily cardiac ailments, diabetes, hypertension, obesity, and knee pain. The company integrates traditional Ayurvedic practices with modern medical diagnostics. It operates a network of multidisciplinary clinics and two cardiac hospitals across various Indian states, offering clinical consultations, specialized Ayurvedic procedures, and chronic disease reversal programs. Additionally, the company is involved in the research, development, and sale of proprietary Ayurvedic medicines, health supplements, and wellness products, which are distributed through its clinics, e-pharmacy platform, and online portals. Its target market includes individuals in India suffering from these chronic conditions, leveraging an integrated approach within the chronic care ecosystem.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save MADHAVBAUG.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
